Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

C A Bellera; N Penel; M Ouali; S Bonvalot; PG Casali; OS Nielsen; M Delannes; S Litiere; F Bonnetain; T S Dabakuyo; R S Benjamin; JY Blay; BN Bui; F Collin; T F Delaney; F Duffaud; T Filleron; M Fiore; H Gelderblom; S (Shanti) George; R Grimer; P Grosclaude; A Gronchi; R Haas; P Hohenberger; R Issels; A Italiano; V Jooste; A Krarup-Hansen; C Pechoux; C Mussi; O Oberlin; S Patel; S Piperno-Neumann; C Raut; I Ray-Coquard; P Rutkowski; S Schuetze; Stefan Sleijfer; E Stoeckle; M Glabbeke; P Woll; S Gourgou-Bourgade; S Mathoulin-Pelissier

doi:10.1093/annonc/mdu360

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

C A Bellera, N Penel, M Ouali, S Bonvalot, PG Casali, OS Nielsen, M Delannes, S Litiere, F Bonnetain, T S Dabakuyo, R S Benjamin, JY Blay, BN Bui, F Collin, T F Delaney, F Duffaud, T Filleron, M Fiore, H Gelderblom, S (Shanti) GeorgeR Grimer, P Grosclaude, A Gronchi, R Haas, P Hohenberger, R Issels, A Italiano, V Jooste, A Krarup-Hansen, C Pechoux, C Mussi, O Oberlin, S Patel, S Piperno-Neumann, C Raut, I Ray-Coquard, P Rutkowski, S Schuetze, Stefan Sleijfer, E Stoeckle, M Glabbeke, P Woll, S Gourgou-Bourgade, S Mathoulin-Pelissier

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

38 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	865-872
Number of pages	8
Journal	Annals of Oncology
Volume	26
Issue number	5
DOIs	https://doi.org/10.1093/annonc/mdu360
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdu360

Cite this

Bellera, C. A., Penel, N., Ouali, M., Bonvalot, S., Casali, PG., Nielsen, OS., Delannes, M., Litiere, S., Bonnetain, F., Dabakuyo, T. S., Benjamin, R. S., Blay, JY., Bui, BN., Collin, F., Delaney, T. F., Duffaud, F., Filleron, T., Fiore, M., Gelderblom, H., ... Mathoulin-Pelissier, S. (2015). Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). Annals of Oncology, 26(5), 865-872. https://doi.org/10.1093/annonc/mdu360

@article{bab9d84e945b4e07a336e88c51de511c,

title = "Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)",

author = "Bellera, {C A} and N Penel and M Ouali and S Bonvalot and PG Casali and OS Nielsen and M Delannes and S Litiere and F Bonnetain and Dabakuyo, {T S} and Benjamin, {R S} and JY Blay and BN Bui and F Collin and Delaney, {T F} and F Duffaud and T Filleron and M Fiore and H Gelderblom and George, {S (Shanti)} and R Grimer and P Grosclaude and A Gronchi and R Haas and P Hohenberger and R Issels and A Italiano and V Jooste and A Krarup-Hansen and C Pechoux and C Mussi and O Oberlin and S Patel and S Piperno-Neumann and C Raut and I Ray-Coquard and P Rutkowski and S Schuetze and Stefan Sleijfer and E Stoeckle and M Glabbeke and P Woll and S Gourgou-Bourgade and S Mathoulin-Pelissier",

year = "2015",

doi = "10.1093/annonc/mdu360",

language = "Undefined/Unknown",

volume = "26",

pages = "865--872",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "5",

}

Bellera, CA, Penel, N, Ouali, M, Bonvalot, S, Casali, PG, Nielsen, OS, Delannes, M, Litiere, S, Bonnetain, F, Dabakuyo, TS, Benjamin, RS, Blay, JY, Bui, BN, Collin, F, Delaney, TF, Duffaud, F, Filleron, T, Fiore, M, Gelderblom, H, George, S, Grimer, R, Grosclaude, P, Gronchi, A, Haas, R, Hohenberger, P, Issels, R, Italiano, A, Jooste, V, Krarup-Hansen, A, Pechoux, C, Mussi, C, Oberlin, O, Patel, S, Piperno-Neumann, S, Raut, C, Ray-Coquard, I, Rutkowski, P, Schuetze, S, Sleijfer, S, Stoeckle, E, Glabbeke, M, Woll, P, Gourgou-Bourgade, S & Mathoulin-Pelissier, S 2015, 'Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)', Annals of Oncology, vol. 26, no. 5, pp. 865-872. https://doi.org/10.1093/annonc/mdu360

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). / Bellera, C A; Penel, N; Ouali, M et al.

In: Annals of Oncology, Vol. 26, No. 5, 2015, p. 865-872.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

AU - Bellera, C A

AU - Penel, N

AU - Ouali, M

AU - Bonvalot, S

AU - Casali, PG

AU - Nielsen, OS

AU - Delannes, M

AU - Litiere, S

AU - Bonnetain, F

AU - Dabakuyo, T S

AU - Benjamin, R S

AU - Blay, JY

AU - Bui, BN

AU - Collin, F

AU - Delaney, T F

AU - Duffaud, F

AU - Filleron, T

AU - Fiore, M

AU - Gelderblom, H

AU - George, S (Shanti)

AU - Grimer, R

AU - Grosclaude, P

AU - Gronchi, A

AU - Haas, R

AU - Hohenberger, P

AU - Issels, R

AU - Italiano, A

AU - Jooste, V

AU - Krarup-Hansen, A

AU - Pechoux, C

AU - Mussi, C

AU - Oberlin, O

AU - Patel, S

AU - Piperno-Neumann, S

AU - Raut, C

AU - Ray-Coquard, I

AU - Rutkowski, P

AU - Schuetze, S

AU - Sleijfer, Stefan

AU - Stoeckle, E

AU - Glabbeke, M

AU - Woll, P

AU - Gourgou-Bourgade, S

AU - Mathoulin-Pelissier, S

PY - 2015

Y1 - 2015

U2 - 10.1093/annonc/mdu360

DO - 10.1093/annonc/mdu360

M3 - Article

VL - 26

SP - 865

EP - 872

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 5

ER -